NEW YORK CITY, NY – Feb. 17, 2026 – ArgenTag, a provider of high-resolution and accessible single-cell analysis solutions, announced today it has joined the PacBio Compatible Partner Program. The co-marketing agreement confirms the compatibility of ArgenTag's Single-Cell RNA Library Kit with PacBio's Kinnex RNA kits, enabling researchers to achieve long-read isoform sequencing at single-cell resolution.

We are thrilled to announce a strategic funding with participation from IndieBio (SOSV), Arben Ventures, Draper Cygnus and GRIDX to accelerate adoption of ArgenTag’s Single-Cell Long-Read platform.

We are absolutely thrilled to see ArgenTag featured today on the  Nasdaq  billboard in Times Square! What a special moment and powerful recognition for our team.  ArgenTag Featured on Nasdaq as a BioTools Innovator. This display celebrates the completion of the prestigious BioTools Innovator program. Being selected as one of 31 elite life science tools companies of the year, chosen from over 400 applicants worldwide, provides incredible validation of our technology and vision